ARCHIVES

FDA Adopts Plan For Drug Approval After Phase 2; Chabner Unconvinced

This article is from The Cancer Letter archive.

Vol. 14 No. 43 | November 4, 1988

Download PDF Visit The Full Archive

Related Articles

Top Management Shifts At Bristol-Myers Squibb Oncology, R&D Units

October 6, 1995

Amgen, J&J Defend ESA Indications.

March 21, 2008

Lenalidomide Maintenance Increased PFS and Survival

May 25, 2012

Antigenics Begins Phase II Trial Of Oncophage for NHL.

March 31, 2000

Obituary: Martin Abeloff, 65, Cancer Center Director At Johns Hopkins.

September 21, 2007

Nobel Laureate Gilman Prepares to Leave The Texas Cancer Agency—Can it Survive?

September 28, 2012